{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T12:17:57Z","timestamp":1758457077880,"version":"3.44.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA133235","1R03CA194795"],"award-info":[{"award-number":["R01CA133235","1R03CA194795"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microvascular Research"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.mvr.2021.104305","type":"journal-article","created":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T10:45:36Z","timestamp":1640342736000},"page":"104305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Down Syndrome Candidate Region 1 Isoform 1L regulated tumor growth by targeting both angiogenesis and tumor cells"],"prefix":"10.1016","volume":"140","author":[{"given":"Chen","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengfei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gengming","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiqiang","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dezheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiyan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mvr.2021.104305_bb0005","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/468770a","article-title":"Cancer: tumour stem cells switch sides","volume":"468","author":"Bautch","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.mvr.2021.104305_bb0010","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.mrfmmm.2004.05.021","article-title":"Beta-catenin-mediated signaling: a molecular target for early chemopreventive intervention","volume":"555","author":"Clapper","year":"2004","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mvr.2021.104305_bb0015","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1006\/abbi.1997.0109","article-title":"Hamster adapt78 mRNA is a down syndrome critical region homologue that is inducible by oxidative stress","volume":"342","author":"Crawford","year":"1997","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.mvr.2021.104305_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.mvr.2019.103955","article-title":"The novel axis of YAP1, transcription enhancer factor 3 and down syndrome candidate region 1 isoform 1L is a common signaling pathway downstream of several angiogenic factors","volume":"129","author":"Cui","year":"2020","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.mvr.2021.104305_bb0025","first-page":"317","article-title":"Leaky tumor vessels: consequences for tumor stroma generation and for solid tumor therapy","volume":"354A","author":"Dvorak","year":"1990","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/j.mvr.2021.104305_bb0030","doi-asserted-by":"crossref","first-page":"166","DOI":"10.4049\/jimmunol.122.1.166","article-title":"Induction of a fibrin-gel investment: an early event in line 10 hepatocarcinoma growth mediated by tumor-secreted products","volume":"122","author":"Dvorak","year":"1979","journal-title":"J. Immunol."},{"key":"10.1016\/j.mvr.2021.104305_bb0035","first-page":"96","article-title":"(1984) fibrin formation: implications for tumor growth and metastasis","volume":"22","author":"Dvorak","year":"1984","journal-title":"Dev. Oncol."},{"key":"10.1016\/j.mvr.2021.104305_bb0040","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nrclinonc.2011.21","article-title":"Antiangiogenic therapy: impact on invasion, disease progression, and metastasis","volume":"8","author":"Ebos","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.mvr.2021.104305_bb0045","doi-asserted-by":"crossref","first-page":"17069","DOI":"10.1073\/pnas.0708148104","article-title":"Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacy","volume":"104","author":"Ebos","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mvr.2021.104305_bb0050","doi-asserted-by":"crossref","first-page":"38787","DOI":"10.1074\/jbc.M102829200","article-title":"Chronic overexpression of the calcineurin inhibitory gene DSCR1 (Adapt78) is associated with Alzheimer's disease","volume":"276","author":"Ermak","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mvr.2021.104305_bb0055","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1096\/fj.01-0846com","article-title":"The DSCR1 (Adapt78) isoform 1 protein calcipressin 1 inhibits calcineurin and protects against acute calcium-mediated stress damage, including transient oxidative stress","volume":"16","author":"Ermak","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.mvr.2021.104305_bb0060","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1006\/geno.1997.4866","article-title":"Genomic organization, alternative splicing, and expression patterns of the DSCR1 (Down syndrome candidate region 1) gene","volume":"44","author":"Fuentes","year":"1997","journal-title":"Genomics"},{"key":"10.1016\/j.mvr.2021.104305_bb0065","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s11912-012-0242-z","article-title":"VEGF inhibition, hypertension, and renal toxicity","volume":"14","author":"Hayman","year":"2012","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.mvr.2021.104305_bb0070","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1084\/jem.20091846","article-title":"Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma","volume":"207","author":"Helfrich","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.mvr.2021.104305_bb0075","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1182\/blood-2004-01-0273","article-title":"Down syndrome critical region protein1 (DSCR1), a novel VEGF target gene that regulates expression of inflammatory markers on activated endothelial cells","volume":"104","author":"Hesser","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.mvr.2021.104305_bb0080","article-title":"A novel transcriptional complex on the VE-cadherin promoter regulated the downregulation of VE-cadherin in the down syndrome candidate region 1 isoform 1L- mediated angiogenesis","volume":"104209","author":"Hou","year":"2021","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.mvr.2021.104305_bb0085","first-page":"253","article-title":"Histopathologic findings and establishment of novel tumor lines from spontaneous tumors in FVB\/N mice","volume":"58","author":"Huang","year":"2008","journal-title":"Comp Med"},{"key":"10.1016\/j.mvr.2021.104305_bb0090","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nm.2072","article-title":"Real-time imaging reveals the single steps of brain metastasis formation","volume":"16","author":"Kienast","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.mvr.2021.104305_bb0095","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1006\/abbi.1998.1059","article-title":"adapt78, a stress-inducible mRNA, is related to the glucose-regulated protein family of genes","volume":"368","author":"Leahy","year":"1999","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.mvr.2021.104305_bb0100","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.bbagen.2009.08.005","article-title":"Down syndrome candidate region-1 protein interacts with tollip and positively modulates interleukin-1 receptor-mediated signaling","volume":"1790","author":"Lee","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mvr.2021.104305_bb0105","doi-asserted-by":"crossref","first-page":"6073","DOI":"10.1158\/0008-5472.CAN-11-1704","article-title":"DLL4-notch signaling mediates tumor resistance to anti-VEGF therapy in vivo","volume":"71","author":"Li","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.mvr.2021.104305_bb0110","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1161\/01.ATV.0000098644.03153.6F","article-title":"Vascular endothelial growth factor-regulated gene expression in endothelial cells: KDR-mediated induction of Egr3 and the related nuclear receptors Nur77, Nurr1, and Nor1","volume":"23","author":"Liu","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.mvr.2021.104305_bb0115","doi-asserted-by":"crossref","first-page":"34159","DOI":"10.1074\/jbc.M806338200","article-title":"Transcription enhancer factor 3 (TEF3) mediates the expression of down syndrome candidate region 1 isoform 1 (DSCR1-1L) in endothelial cells","volume":"283","author":"Liu","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mvr.2021.104305_bb0120","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1096\/fj.10-167619","article-title":"Requirement of the nuclear localization of transcription enhancer factor 3 for proliferation, migration, tube formation, and angiogenesis induced by vascular endothelial growth factor","volume":"25","author":"Liu","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.mvr.2021.104305_bb0125","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/1947601909356574","article-title":"Mechanisms of resistance to anti-angiogenic therapy and development of third-generation anti-angiogenic drug candidates","volume":"1","author":"Loges","year":"2010","journal-title":"Genes Cancer"},{"key":"10.1016\/j.mvr.2021.104305_bb0130","doi-asserted-by":"crossref","first-page":"50537","DOI":"10.1074\/jbc.M406454200","article-title":"VEGF- and thrombin-induced termination factor, down syndrome critical region-1, attenuates endothelial cell proliferation, and angiogenesis","volume":"279","author":"Minami","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mvr.2021.104305_bb0135","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0092-8674(00)81573-1","article-title":"A calcineurin-dependent transcriptional pathway for cardiac hypertrophy","volume":"93","author":"Molkentin","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.mvr.2021.104305_bb0140","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/23060","article-title":"IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1","volume":"400","author":"Musaro","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.mvr.2021.104305_bb0145","first-page":"560","article-title":"Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis","volume":"118","author":"Popivanova","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mvr.2021.104305_bb0150","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1158\/1541-7786.MCR-06-0126","article-title":"Down syndrome candidate region 1 isoform 1 mediates angiogenesis through the calcineurin-NFAT pathway","volume":"4","author":"Qin","year":"2006","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.mvr.2021.104305_bb0155","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1182\/blood-2012-07-443903","article-title":"The vascular permeabilizing factors histamine and serotonin induce angiogenesis through TR3\/Nur77 and subsequently truncate it through thrombospondin-1","volume":"121","author":"Qin","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.mvr.2021.104305_bb0160","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/nature09557","article-title":"Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells","volume":"468","author":"Ricci-Vitiani","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.mvr.2021.104305_bb0165","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/23054","article-title":"Skeletal muscle hypertrophy is mediated by a Ca2+-dependent calcineurin signalling pathway","volume":"400","author":"Semsarian","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.mvr.2021.104305_bb0170","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1126\/science.6823562","article-title":"Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid","volume":"219","author":"Senger","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.mvr.2021.104305_bb0175","first-page":"5629","article-title":"A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines","volume":"46","author":"Senger","year":"1986","journal-title":"Cancer Res."},{"key":"10.1016\/j.mvr.2021.104305_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4062\/biomolther.2013.113","article-title":"VEGF-VEGFR signals in health and disease","volume":"22","author":"Shibuya","year":"2014","journal-title":"Biomol. Ther. (Seoul)"},{"key":"10.1016\/j.mvr.2021.104305_bb0185","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.canlet.2012.03.008","article-title":"Anti-angiogenesis therapy in cancer: current challenges and future perspectives","volume":"320","author":"Shojaei","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.mvr.2021.104305_bb0190","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/nbt1323","article-title":"Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells","volume":"25","author":"Shojaei","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.mvr.2021.104305_bb0195","doi-asserted-by":"crossref","first-page":"6742","DOI":"10.1073\/pnas.0902280106","article-title":"G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models","volume":"106","author":"Shojaei","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mvr.2021.104305_bb0200","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nature09624","article-title":"Glioblastoma stem-like cells give rise to tumour endothelium","volume":"468","author":"Wang","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.mvr.2021.104305_bb0205","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.bbrc.2004.06.176","article-title":"VEGF selectively induces down syndrome critical region 1 gene expression in endothelial cells: a mechanism for feedback regulation of angiogenesis?","volume":"321","author":"Yao","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Microvascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026286221001758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026286221001758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:00:15Z","timestamp":1758434415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026286221001758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":41,"alternative-id":["S0026286221001758"],"URL":"https:\/\/doi.org\/10.1016\/j.mvr.2021.104305","relation":{},"ISSN":["0026-2862"],"issn-type":[{"type":"print","value":"0026-2862"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Down Syndrome Candidate Region 1 Isoform 1L regulated tumor growth by targeting both angiogenesis and tumor cells","name":"articletitle","label":"Article Title"},{"value":"Microvascular Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mvr.2021.104305","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104305"}}